Business Wire

Emulate Unveils Chip-A1, Expanding Organ-on-a-Chip Technology Applications Within the Cancer and Cosmetics Markets

BOSTON--(BUSINESS WIRE)--Emulate, Inc., the leading provider of next-generation in vitro models, today announced the launch of the Emulate Chip-A1™ Accessible Chip through an early access program.
FierceBiotech

Organ-chip developer Emulate raises $36M in VC funding

Organ-on-a-chip developer Emulate has gathered $36 million in series C financing, and plans to expand its platform to include a wider range of disease models for drug efficacy testing. The ...
FierceBiotech

Organ-on-a-chip maker Emulate secures $82M to expand scientific, commercial efforts

The organ-on-a-chip developer Emulate has raised $82 million to boost its offerings aimed at replicating human biology through easier-to-manage in vitro cellular models. Used in past drug development ...
Business Wire

Emulate Announces New Gene Therapy Application Enabling Accelerated Development of Treatments for Genetic Diseases with Organ-on-a-Chip Technology

BOSTON--(BUSINESS WIRE)--Emulate, Inc., a leading provider of next-generation in vitro models, today announced the launch of its new adeno-associated virus (AAV) transduction application for the Liver ...
BioWorld

Emulate launches new AAV transduction application for Liver-Chip

Emulate Inc. has launched a new adeno-associated virus (AAV) transduction application for the Liver-Chip that enables gene therapy researchers to test the delivery efficiency and safety of AAV vectors ...